Nathalie Contentin

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

Richard Childs, Allen Chernoff, Nathalie Contentin et al. · New England Journal of Medicine · 2000 · 1K citations · Full text

Medicine, Hematology, Oncology +15

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Sylvie Castaigné, Cécile Pautas, Christine Terré et al. · The Lancet · 2012 · 995 citations

Medicine, Hematology, Pharmacology +10

Engraftment Kinetics After Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation: Full Donor T-Cell Chimerism Precedes Alloimmune Responses

Richard Childs, Emmanuel Clave, Nathalie Contentin et al. · Blood · 1999 · 528 citations

Medicine, Hematology, Immunology +12

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

A.-L. Taksin, Ollivier Legrand, Emmanuel Raffoux et al. · Leukemia · 2006 · 288 citations

Medicine, Oncology, Pharmacology +10

Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group

Nicolas Boissel, Olivier Nibourel, Aline Renneville et al. · Journal of Clinical Oncology · 2010 · 217 citations

Medicine, Molecular Genetics, Oncology +14